Skip to main content
ERNA
NASDAQ Life Sciences

ERNA-101 On Track for Q3 2026 IND Submission, First-in-Human Study; Preclinical Data Strong

Tom Rudovsky · Reported by GlobeNewswire
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
9
Price
$6.292
Mkt Cap
$7.115M
52W Low
$3.183
52W High
$71.498
52W Position info
98% above low
Off High info
91% below high
Rel. Volume
Market data snapshot near publication time

ERNA sits 98% above its 52-week low of $3.183.

Summary

Ernexa Therapeutics announced its lead candidate, ERNA-101, is on track for a Q3 2026 IND submission and Q4 2026 first-in-human study, marking a transition to a clinical-stage company. This follows previous positive updates on ERNA-101's progress and comes after the company recently completed a $10.5 million financing, addressing prior liquidity concerns. Preclinical data for ERNA-101 showed complete tumor clearance and 100% long-term survival in ovarian cancer models, which is highly compelling. This progress, coupled with the financing, significantly de-risks the company's near-term development. Traders will watch for the IND submission in Q3 2026 and the start of the Phase 1 study in Q4 2026.

At the time of this announcement, ERNA was trading at $6.29 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $7.1M. The 52-week trading range was $3.18 to $71.50. This news item was assessed with positive market sentiment and an importance score of 9 out of 10. Source: GlobeNewswire.


Price Chart

Share this article

Copied!

ERNA - Latest Insights

ERNA
Nov 06, 2026, 4:50 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $1.88
Real-time Price: $1.96 info
Change: +$0.080 (+4%) info
Market Cap: $3.069M info
ERNA
Sep 30, 2026, 8:32 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $3.52
Real-time Price: $1.96 info
Change: -$1.56 (-44%) info
Market Cap: $3.069M info
ERNA
Sep 15, 2026, 8:42 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $3.54
Real-time Price: $1.96 info
Change: -$1.58 (-45%) info
Market Cap: $3.069M info
ERNA
Aug 06, 2026, 5:31 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $4.57
Real-time Price: $1.96 info
Change: -$2.61 (-57%) info
Market Cap: $3.069M info
ERNA
Jul 15, 2026, 7:50 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $11.04
Real-time Price: $1.96 info
Change: -$9.08 (-82%) info
Market Cap: $3.069M info